Cardiometabolic Diseases

Our research in cardiometabolic disorders explicitly targets cardiovascular diseases & diabetes in Pakistan, where an estimated 33 million people are living with type 2 diabetes, with a 26.7% prevalence rate in adults.*

Source :* Federation, I. D. (2021). Diabetes in Pakistan (2021). Retrieved from International Diabetes Federation:

Real-World Data (RWD) Experiences

Metrics Research contributions to these Real-World Data (RWD) studies provided comprehensive insights into patient experiences, treatment outcomes, and healthcare trends, supporting sponsors in making informed decisions.

Enrollment of subjects with hypertension.
Subjects enrolled undergoing implantation of a cardiac stent.
Inclusion of diabetic patients for real-world insights on marketed insulin.
Patients enrolled for the evaluation of Lp(a).

Bio-equivalence Studies

Conducted multiple BE studies on single and combination pharmacotherapeutic molecules.

Experiences in Diabetes Mellitus 

Multi-center observational study on diabetes.

Provided services for the statistical analysis of real-world data on metabolic disorders, including diabetes.

Conducted Bioequivalence (BE) studies on anti-diabetic medication.

Expert medical writing services related to a range of cardiometabolic diseases, including diabetes, tailored to the study-specific needs of sponsors.

Trial Insurance

  • Customized coverage for clinical trial participant.
  • Risk assessment and tailored insurance solutions
  • Compliance with international and national level regulations.

IT Solutions

  • Enabling collaborations with the EDC tool vendor.
  • Providing IT-enabled data management support.
  • Integrating data from various sources to facilitate efficient data management.
  • Monitoring site performance for optimizing the use of resources.
  • Maintaining audit trails for tracking changes to ensure data integrity through EDC tools.

Specimen Shipment & Handling

  • Secure and compliant handling of biological specimens.
  • Temperature-controlled packaging and shipping.
  • Collaborative services with global logistics network for specimen transportation.
  • Ensuring regulatory compliance for international shipments.
  • Expertise in managing various specimen types, including blood, tissue, and urine.

Clinical Trial Ancillary Supplies

  • Enabling the sponsors with the ancillary supplies for clinical trials.
  • Comprehensive inventory management and tracking.
  • Customizing supply chain solutions to meet trial-specific needs.
  • Ensuring timely supply services.
  • Providing cost efficient solutions to optimize trial budgets.

IP/ Placebo / Comparator Sourcing

  • In-house services for sourcing of Investigational Products, comparators, and placebos.
  • Collaboration with suppliers and manufacturers.
  • Experienced team for procurement and logistics management.

Central Laboratory Testing

  • Collaborative services for diagnostic and clinical testing.
  • Enabling sponsors to evaluate diverse range of clinical endpoints through diagnostic tests.
  • Meeting quality standards and regional regulatory compliance.
  • Standardized procedures for authentic and credible outcomes.

Percentage Of Total Contributions

Head Office:

Karachi: Plot No. B-10, Block 16, WCHS, KDA Scheme No.24, Gulshan E Iqbal, Karachi – Pakistan.

Regional Office:

Flat No. 2, first floor, 2-C Plaza ( First floor of M.A Dental Clinic) Pakeeza Market, Sector I-8/4, Islamabad, Pakistan

Regional Presence:

  • Sindh
  • Punjab
  • Balochistan
  • Khyber Pakhtunkhwa